B-cell Lymphoma
B-cell lymphoma is a type of cancer that originates in B-cells, which are part of the immune system. It can affect how your body fights infections and can lead to symptoms like swollen lymph nodes, fever, and weight loss.
Lymphoma Treatment: STP938
We are testing a new drug called STP938 for adults with relapsed or refractory B-cell and T-cell lymphomas. The goal is to see if it can provide a new treatment option for those who have not responded to other therapies.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
T-cell Lymphoma
T-cell lymphoma is a type of cancer that starts in T-cells, which are crucial for the immune response. It can cause symptoms such as swollen lymph nodes, skin rashes, and fevers.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Bordeaux
service de Dermatologie
Bordeaux, France
Institut Paoli-Calmettes
Service d‘hématologie
Marseille, France
Centre Hospitalier Universitaire De Nantes
Département d‘Hématologie Clinique
Nantes, France
Sponsor: Step Pharma
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.